THE ROTHBURY PRACTICE
3 MARKET PLACE, ROTHBURY, MORPETH
Stroke 12
The % of patients with a stroke shown to be non-haemorrhagic, or a history of TIA, who have a record that an anti-platelet agent (aspirin, clopidogrel, dipyridamole or a combination), or an anti-coagulant is being taken (unless a contraindication or side-effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| STROKE 9 | 2005 | 84 | 87 | 96.6% | |
| STROKE 9 | 2006 | 97 | 103 | 94.2% | |
| Stroke 12 | 2007 | 106 | 110 | 96.4% | |
| Stroke 12 | 2008 | 110 | 113 | 97.3% | |
| Stroke 12 | 2009 | 119 | 125 | 95.2% | |
| Stroke 12 | 2010 | 130 | 135 | 96.3% | |
| STROKE 12 | 2011 | 136 | 143 | 95.1% | |
| STROKE 12 | 2012 | 136 | 138 | 98.6% | |
| STROKE 12 | 2013 | 129 | 132 | 97.7% | |
| STIA007 | 2014 | 127 | 129 | 98.4% | |
| STIA007 | 2015 | 122 | 126 | 96.8% | |
| STIA007 | 2016 | 126 | 127 | 99.2% | |
| STIA007 | 2017 | 122 | 127 | 96.1% | |
| STIA007 | 2018 | 125 | 129 | 96.9% | |
| STIA007 | 2019 | 132 | 133 | 99.2% | |
| STIA007 | 2020 | 133 | 142 | 93.7% | |
| STIA007 | 2021 | 129 | 140 | 92.1% | |
| STIA007 | 2022 | 132 | 147 | 89.8% | |
| STIA007 | 2023 | 132 | 136 | 97.1% |
